Oncology Research2026，Vol.34Issue(8)：P.605-614,10.DOI:10.32604/or.2026.083192
Excellent Survival Outcome in a Patient Receiving NALIRIFOX for Metastatic Pancreatic Adenocarcinoma:A Case Report
Abdullah Esmail 1Waseem Abdelrahim 2Ebtesam Al-Najjar 1Raed Zaidan 3Tahrir Abdelrahim1
作者信息
- 1. Section of GI Oncology,Houston Methodist Neal Cancer Center,Houston Methodist Hospital,Houston,TX,USA
- 2. Michael E.DeBakey HS for Health Professions,Houston,TX,USA
- 3. The University of Houston-Clear Lake,Houston,TX,USA
- 折叠
摘要
关键词
NALIRIFOX/long-term survival/pancreatic ductal adenocarcinoma/durable response/case report分类
医药卫生引用本文复制引用
Abdullah Esmail,Waseem Abdelrahim,Ebtesam Al-Najjar,Raed Zaidan,Tahrir Abdelrahim..Excellent Survival Outcome in a Patient Receiving NALIRIFOX for Metastatic Pancreatic Adenocarcinoma:A Case Report[J].Oncology Research,2026,34(8):P.605-614,10.
